BlackRock Fund Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $36.2M | Buy |
2,270,297
+679,195
| +43% | +$10.8M | 0.01% | 1873 |
|
|
2016
Q3 | $26.5M | Buy |
1,591,102
+74,095
| +5% | +$1.23M | 0.01% | 1934 |
|
|
2016
Q2 | $17M | Sell |
1,517,007
-125,063
| -8% | -$1.4M | ﹤0.01% | 2116 |
|
|
2016
Q1 | $13.7M | Buy |
1,642,070
+19,224
| +1% | +$161K | ﹤0.01% | 2193 |
|
|
2015
Q4 | $15.1M | Sell |
1,622,846
-61,938
| -4% | -$577K | ﹤0.01% | 2199 |
|
|
2015
Q3 | $19M | Buy |
1,684,784
+43,073
| +3% | +$486K | ﹤0.01% | 2017 |
|
|
2015
Q2 | $20.8M | Buy |
1,641,711
+156,520
| +11% | +$1.99M | 0.01% | 2093 |
|
|
2015
Q1 | $13.8M | Sell |
1,485,191
-68,098
| -4% | -$633K | ﹤0.01% | 2269 |
|
|
2014
Q4 | $22.2M | Buy |
1,553,289
+323,759
| +26% | +$4.64M | 0.01% | 2005 |
|
|
2014
Q3 | $12.8M | Sell |
1,229,530
-14,813
| -1% | -$154K | ﹤0.01% | 2215 |
|
|
2014
Q2 | $20.1M | Sell |
1,244,343
-91,696
| -7% | -$1.48M | 0.01% | 2018 |
|
|
2014
Q1 | $21.7M | Buy |
1,336,039
+56,958
| +4% | +$926K | 0.01% | 1955 |
|
|
2013
Q4 | $15.9M | Sell |
1,279,081
-21,050
| -2% | -$261K | ﹤0.01% | 2113 |
|
|
2013
Q3 | $14.2M | Buy |
1,300,131
+331,630
| +34% | +$3.63M | ﹤0.01% | 2150 |
|
|
2013
Q2 | $7.83M | Buy |
+968,501
| New | +$7.83M | ﹤0.01% | 2413 |
|